✦ LIBER ✦

A high serum-soluble interleukin-2 receptor level is associated with a poor outcome of aggressive non-Hodgkin's lymphoma

✍ Scribed by Nozomi Niitsu; Kimiko Iijima; Aki Chizuka

Book ID: 114422979
Publisher: John Wiley and Sons
Year: 2001
Tongue: English
Weight: 182 KB
Volume: 66
Category: Article
ISSN: 0902-4441
DOI: 10.1034/j.1600-0609.2001.00334.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A high serum soluble Fas/APO-1 level is

A high serum soluble Fas/APO-1 level is associated with a poor outcome of aggressive non-Hodgkin’s lymphoma

✍ Niitsu, N; Sasaki, K; Umeda, M 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 118 KB

Serum-soluble tumor necrosis factor rece

Serum-soluble tumor necrosis factor receptor 2 (sTNF-R2) level determines clinical outcome in patients with aggressive non-Hodgkin's lymphoma

✍ Naoe Goto; Hisashi Tsurumi; Masao Takemura; Takeshi Hara; Michio Sawada; Senji K 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 606 KB

Serum-soluble interleukin-2 receptor (sI

Serum-soluble interleukin-2 receptor (sIL-2R) level determines clinical outcome in patients with aggressive non-Hodgkin’s lymphoma: in combination with the International Prognostic Index

✍ Hideko Goto; Hisashi Tsurumi; Masao Takemura; Yoriko Ino-Shimomura; Senji Kasaha 📂 Article 📅 2004 🏛 Springer-Verlag 🌐 English ⚖ 244 KB

Detection of soluble interleukin-2 recep

Detection of soluble interleukin-2 receptor and interleukin-10 in the serum of patients with aggressive non-Hodgkin's lymphoma.Identification of a subset at high risk of treatment failure

✍ Roberto Stasi; Pier Luigi Zinzani; Piero Galieni; Vito Michele Lauta; Eugenio Da 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 875 KB

p53, Mdm2, and c-Myc overexpression is a

p53, Mdm2, and c-Myc overexpression is associated with a poor prognosis in aggressive non-Hodgkin's lymphomas

✍ Katia B.B. Pagnano; Jose Vassallo; Irene Lorand-Metze; Fernando F. Costa; Sara T 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 351 KB 👁 2 views

Serum soluble interleukin-2 receptor (sI

Serum soluble interleukin-2 receptor (sIL-2R) level is associated with the outcome of patients with diffuse large B cell lymphoma treated with R-CHOP regimens

✍ Naoe Goto; Hisashi Tsurumi; Hideko Goto; Yoriko Ino Shimomura; Senji Kasahara; T 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 437 KB